MedTrace Logo

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

NCT04904146 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-03-10

No results posted yet for this study

Summary

A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.

Conditions

  • Mycosis Fungoides
  • Sezary Syndrome

Interventions

DIAGNOSTIC_TEST

Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.

The study aims to perform systematic translational sampling of each patient from study start until end-of-study, or at longest for a three year period for each patient. Treatment will be performed according to clinical routine.

Sponsors & Collaborators

  • Lund University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-02
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04904146 on ClinicalTrials.gov